David P Perry's Net Worth

$2.11 Million

Estimate Recalculated Sep 8, 2024 07:26PM EST

Who is David P Perry?

David P Perry has an estimated net worth of $2.11 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, Evelo Biosciences, Inc., Better Therapeutics, Inc., and NEXPRISE INC.

SEC CIK

David P Perry's CIK is 0001105941

Past Insider Trading and Trends

2021 was David P Perry's most active year for acquiring shares with 10 total transactions. David P Perry's most active month to acquire stocks was the month of April. 2014 was David P Perry's most active year for disposing of shares, totalling 8 transactions. David P Perry's most active month to dispose stocks was the month of November. 2024 saw David P Perry paying a total of $409,999.86 for 2,311,348 shares, this is the most they've acquired in one year. In 2014 David P Perry cashed out on 145,000 shares for a total of $2,630,510.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anacor Pharmaceuticals Inc No price found

President and CEO

David P Perry owns 361,306 units of Common Stock.acquired a total of 285,480 shares in Anacor Pharmaceuticals Inc at a cost of $171,288.00, David also disposed a total of 185,328 shares of Anacor Pharmaceuticals Inc equalling to $3,285,097.51.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.25%
-65.00K
$20.22
-$1,314,396.50
361.31K
Scheduled
Mar 4 - Mar 5
Form 4
—
0
—
—
0
Feb 7
Form 4
-3.40%
-15.00K
$17.00
-$255,006.75
426.31K
Scheduled
Feb 4 - Feb 5
Form 4
-12.84%
-65.00K
$16.32
-$1,061,107.00
441.31K
Scheduled
Jan 8 - Jan 9
Form 4
+93.87%
245.15K
$8.42
-$483,299.26
506.31K
Scheduled
Dec 5 - Dec 9
Form 4
—
0
—
—
0
Apr 12
Form 4
—
0
—
—
0
Mar 13
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found

Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8 - Jun 9
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 12
Form 3
—
0
—
—
0
No matching records found

Better Therapeutics, Inc. (BTTX) Snapshot price: $0.008

Executive Chairman

David P Perry owns 2,416,634 units of Common Stock which is worth $19,333.07. From 2021 to 2024 David P Perry acquired a total of 2,416,634 shares in Better Therapeutics, Inc. at a cost of $1,025,029.89.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+53.27%
839.89K
$0.19
$160,000.00
2.42M
Feb 9
Form 4
+1,397.58%
1.47M
$0.17
$249,999.86
1.58M
Jan 9
Form 4
+3.69%
3.75K
—
—
105.29K
Dec 18
Form 4
+10.45%
1.23M
$0.73
$899,999.55
13.03M
Jul 27
Form 4
—
0
—
—
0
Jun 7
Form 4
+47.49%
4.97M
$0.83
$4,100,000.02
15.43M
Apr 10
Form 4
+97.02%
50K
$2.05
$102,597.54
101.54K
Sep 15 - Sep 16
Form 4
—
0
—
—
0
Jun 9
Form 4
+34.59%
10.83M
$9.97
$3,512,432.48
42.14M
Apr 30 - Oct 28
Form 3
—
0
—
—
0
No matching records found

NEXPRISE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 22
No matching records found